Cognitive dysfunction with tolterodine use

American Journal of Obstetrics and Gynecology

Volumn 197, Issue 2, 2007, Pages

  Salvatore, Stefano ^a   Serati, Maurizio ^a   Cardozo, Linda ^b   Uccella, Stefano ^a   Bolis, Pierfrancesco ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

cognitive dysfunction; neurological impairment; overactive bladder treatment; tolterodine

Indexed keywords

TOLTERODINE;

AGED; AMNESIA; ARTICLE; BASAL GANGLION; BLOOD PRESSURE; CASE REPORT; COGNITIVE DEFECT; DETRUSOR MUSCLE; DRUG DOSE REDUCTION; FEMALE; FRONTAL LOBE; HUMAN; MENTAL DISEASE; OVERACTIVE BLADDER; PATIENT REFERRAL; PRIORITY JOURNAL;

AGED; BENZHYDRYL COMPOUNDS; COGNITION DISORDERS; CRESOLS; FEMALE; HUMANS; PHENYLPROPANOLAMINE; URINARY BLADDER, OVERACTIVE;

EID: 34547597046     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.04.051     Document Type: Article

References (3)

1. Todorova A., Vonderheid-Guth B., and Dimpfel W. Effects of tolterodine, trospium chloride and oxybutynin on the central nervous system. J Clin Pharmacol 41 (2001) 636-644
2. Donnellan C.A., Fook L., McDonald P., and Playfer J.R. Lesson of the week: oxybutynin and cognitive dysfunction. BMJ 315 (1997) 1363-1364
3. Tsao J.W., and Kenneth M.H. Transient memory impairment and hallucinations associated with tolterodine use. N Engl J Med 349 (2003) 2274-2275